Shamburg News · 8-K filed Oct 6, 2026, 5:15 PM EDT

Rocket Pharmaceuticals Enters Up to $150 Million Senior Secured Term Loan with Hercules Capital

RCKT · ROCKET PHARMACEUTICALS, INC.

  • Material agreement
  • Financing
  • Materiality: high

On September 30, 2026, Rocket Pharmaceuticals and subsidiaries entered into a Loan and Security Agreement with Hercules Capital as agent providing up to $150.0 million in senior secured term loans, with a $35.0 million Tranche 1-A advance funded at closing. The Company also issued warrants to the lenders to purchase up to 1,755,853 shares of common stock at $2.99 per share, with 409,699 shares exercisable after the Tranche 1-A closing. The Term Loans mature October 1, 2030, subject to extension upon achieving a specified milestone.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 1.01, 2.03, 3.02, 7.01, 9.01, accession 0001140361-26-038818.

Written from the filing by Shamburg Markets. Figures are as reported by the company.